CuronBiotech Inc
Shaker Heights, OH · Biotech · Private
GSK3 kinase inhibitor for acute myeloid leukemia differentiation therapy
- Grants
- $1.1M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · AML differentiation therapy | $223,080 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · AML differentiation therapy | $290,280 | |
| Federal grant | Department of Health and Human Services · Phase I · AML differentiation therapy | $67,200 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Targeting GSK3 in AML | $268,737 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Targeting GSK3 in AML | $268,737 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3205 | Anaveon | — | — |
| 3206 | IMETABOLIC BIOPHARMA CORPORATION | — | — |
| 3207 | AcePre, LLC | — | — |
| 3208 | CuronBiotech Inc | — | — |
| 3209 | Gerologix, Inc. | — | — |
| 3210 | Culture Robotics, Inc | — | — |
| 3211 | Venomyx, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.